Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Aura Biosciences To Present New Phase 1 Data On Bel-Sar For Non-Muscle Invasive Bladder Cancer In Late-Breaking Session At 40th EAU Congress

Author: Benzinga Newsdesk | March 03, 2025 07:20am

Aura will Participate in the Research Forum at the 40th Annual European Association of Urology Congress
Aura will Host a Virtual Urologic Oncology Investor Event Featuring Key Opinion Leaders at 4:30 pm Eastern Time on March 24, 2025

Posted In: AURA